• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同 NTCP 技术预测 NSCLC 患者接受质子放疗后放射性食管炎的预测性能。

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy.

机构信息

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Department of Radiation Physics, Unit 1150, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

出版信息

Sci Rep. 2022 Jun 2;12(1):9178. doi: 10.1038/s41598-022-12898-8.

DOI:10.1038/s41598-022-12898-8
PMID:35655073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9163134/
Abstract

This study aimed to compare the predictive performance of different modeling methods in developing normal tissue complication probability (NTCP) models for predicting radiation-induced esophagitis (RE) in non-small cell lung cancer (NSCLC) patients receiving proton radiotherapy. The dataset was composed of 328 NSCLC patients receiving passive-scattering proton therapy and 41.6% of the patients experienced ≥ grade 2 RE. Five modeling methods were used to build NTCP models: standard Lyman-Kutcher-Burman (sLKB), generalized LKB (gLKB), multivariable logistic regression using two variable selection procedures-stepwise forward selection (Stepwise-MLR), and least absolute shrinkage and selection operator (LASSO-MLR), and support vector machines (SVM). Predictive performance was internally validated by a bootstrap approach for each modeling method. The overall performance, discriminative ability, and calibration were assessed using the Negelkerke R, area under the receiver operator curve (AUC), and Hosmer-Lemeshow test, respectively. The LASSO-MLR model showed the best discriminative ability with an AUC value of 0.799 (95% confidence interval (CI): 0.763-0.854), and the best overall performance with a Negelkerke R value of 0.332 (95% CI: 0.266-0.486). Both of the optimism-corrected Negelkerke R values of the SVM and sLKB models were 0.301. The optimism-corrected AUC of the gLKB model (0.796) was higher than that of the SVM model (0.784). The sLKB model had the smallest optimism in the model variation and discriminative ability. In the context of classification and probability estimation for predicting the NTCP for radiation-induced esophagitis, the MLR model developed with LASSO provided the best predictive results. The simplest LKB modeling had similar or even better predictive performance than the most complex SVM modeling, and it was least likely to overfit the training data. The advanced machine learning approach might have limited applicability in clinical settings with a relatively small amount of data.

摘要

本研究旨在比较不同建模方法在开发用于预测接受质子放射治疗的非小细胞肺癌(NSCLC)患者放射性食管炎(RE)的正常组织并发症概率(NTCP)模型中的预测性能。该数据集由 328 名接受被动散射质子治疗的 NSCLC 患者组成,其中 41.6%的患者发生了≥2 级 RE。使用五种建模方法来构建 NTCP 模型:标准 Lyman-Kutcher-Burman(sLKB)、广义 LKB(gLKB)、使用两种变量选择程序逐步向前选择(Stepwise-MLR)的多变量逻辑回归、最小绝对收缩和选择算子(LASSO-MLR)以及支持向量机(SVM)。使用自举方法对每种建模方法进行内部验证。使用 Negelkerke R、接收者操作特征曲线下面积(AUC)和 Hosmer-Lemeshow 检验分别评估整体性能、判别能力和校准。LASSO-MLR 模型表现出最佳的判别能力,AUC 值为 0.799(95%置信区间(CI):0.763-0.854),最佳整体性能的 Negelkerke R 值为 0.332(95% CI:0.266-0.486)。SVM 和 sLKB 模型的优化校正 Negelkerke R 值均为 0.301。gLKB 模型的优化校正 AUC(0.796)高于 SVM 模型(0.784)。sLKB 模型在模型变化和判别能力方面具有最小的优化。在分类和概率估计的背景下,用于预测放射性食管炎的 NTCP,基于 LASSO 的 MLR 模型提供了最佳的预测结果。最简单的 LKB 建模具有与最复杂的 SVM 建模相似甚至更好的预测性能,并且最不可能过度拟合训练数据。在数据量相对较少的临床环境中,先进的机器学习方法的适用性可能有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84b6/9163134/fdff0a5e6f48/41598_2022_12898_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84b6/9163134/acce187b3390/41598_2022_12898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84b6/9163134/fdff0a5e6f48/41598_2022_12898_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84b6/9163134/acce187b3390/41598_2022_12898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84b6/9163134/fdff0a5e6f48/41598_2022_12898_Fig2_HTML.jpg

相似文献

1
Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy.不同 NTCP 技术预测 NSCLC 患者接受质子放疗后放射性食管炎的预测性能。
Sci Rep. 2022 Jun 2;12(1):9178. doi: 10.1038/s41598-022-12898-8.
2
Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.利曼-库彻-伯曼正常组织并发症概率模型在接受质子放射治疗的非小细胞肺癌患者放射性食管炎中的应用。
Radiother Oncol. 2020 May;146:200-204. doi: 10.1016/j.radonc.2020.03.003. Epub 2020 Apr 30.
3
Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model.采用 Lyman NTCP 模型分析非小细胞肺癌患者急性放射性食管炎。
Radiother Oncol. 2010 Dec;97(3):449-54. doi: 10.1016/j.radonc.2010.09.025. Epub 2010 Nov 8.
4
Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients.预测肺癌患者放射性肺炎:一种基于等效均匀剂量的容积调强弧形放疗患者机器学习方法
Front Oncol. 2024 Jan 31;14:1343170. doi: 10.3389/fonc.2024.1343170. eCollection 2024.
5
Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.非小细胞肺癌行根治性三维适形放疗、调强放疗或质子束放疗后发生高级别食管炎的预测因素。
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1010-6. doi: 10.1016/j.ijrobp.2012.01.071. Epub 2012 Aug 21.
6
Toward personalized dose-prescription in locally advanced non-small cell lung cancer: Validation of published normal tissue complication probability models.局部晚期非小细胞肺癌的个体化剂量处方:已发表的正常组织并发症概率模型的验证。
Radiother Oncol. 2019 Sep;138:45-51. doi: 10.1016/j.radonc.2019.05.011. Epub 2019 May 27.
7
Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.非小细胞肺癌适形放疗患者急性食管炎的正常组织并发症概率建模
Radiother Oncol. 2005 Nov;77(2):176-81. doi: 10.1016/j.radonc.2005.10.001. Epub 2005 Oct 26.
8
NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients.IMRT或质子治疗后胸段癌患者严重放射性皮炎的NTCP模型
Front Oncol. 2020 Mar 17;10:344. doi: 10.3389/fonc.2020.00344. eCollection 2020.
9
External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy.局部晚期非小细胞肺癌患者接受调强(放化疗)后急性食管毒性的 NTCP 模型的外部验证。
Radiother Oncol. 2018 Nov;129(2):249-256. doi: 10.1016/j.radonc.2018.07.021. Epub 2018 Sep 18.
10
Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?辐射诱发心脏瓣膜功能障碍的并发症概率模型:心肺相互作用起作用吗?
PLoS One. 2014 Oct 31;9(10):e111753. doi: 10.1371/journal.pone.0111753. eCollection 2014.

引用本文的文献

1
Improving Prediction of Complications Post-Proton Therapy in Lung Cancer Using Large Language Models and Meta-Analysis.利用大语言模型和荟萃分析提高肺癌质子治疗后并发症预测能力。
Cancer Control. 2024 Jan-Dec;31:10732748241286749. doi: 10.1177/10732748241286749.
2
Benchmarking machine learning approaches to predict radiation-induced toxicities in lung cancer patients.用于预测肺癌患者辐射诱导毒性的机器学习方法基准测试
Clin Transl Radiat Oncol. 2023 May 19;41:100640. doi: 10.1016/j.ctro.2023.100640. eCollection 2023 Jul.
3
Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis.

本文引用的文献

1
Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults.在临床环境中,逻辑回归与优化的机器学习算法具有相似的性能:应用于区分年轻成年人的1型和2型糖尿病。
Diagn Progn Res. 2020 Jun 4;4:6. doi: 10.1186/s41512-020-00075-2. eCollection 2020.
2
Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial.基于模型的质子治疗试验方法的观点:一项肺癌随机试验的回顾性研究。
Radiother Oncol. 2020 Jun;147:8-14. doi: 10.1016/j.radonc.2020.02.022. Epub 2020 Mar 27.
3
非小细胞肺癌放疗中的机器学习:一项文献计量分析。
Front Oncol. 2023 Mar 17;13:1082423. doi: 10.3389/fonc.2023.1082423. eCollection 2023.
Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
利曼-库彻-伯曼正常组织并发症概率模型在接受质子放射治疗的非小细胞肺癌患者放射性食管炎中的应用。
Radiother Oncol. 2020 May;146:200-204. doi: 10.1016/j.radonc.2020.03.003. Epub 2020 Apr 30.
4
Incorporating NTCP into Randomized Trials of Proton Versus Photon Therapy.将正常组织并发症概率(NTCP)纳入质子治疗与光子治疗随机试验
Int J Part Ther. 2019 Winter;5(3):24-32. doi: 10.14338/IJPT-18-00038.1. Epub 2019 Mar 21.
5
A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.一种定量临床决策支持策略,用于确定哪些口咽头颈部癌症患者可能从质子放射治疗中获益最大。
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):540-552. doi: 10.1016/j.ijrobp.2018.11.039. Epub 2018 Nov 26.
6
Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma.使用影像学和生物标志物对肝癌放射治疗后正常组织并发症进行建模。
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):335-343. doi: 10.1016/j.ijrobp.2017.10.005.
7
Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.局部晚期非小细胞肺癌同步放化疗的急性和晚期毒性反应
Cancers (Basel). 2017 Sep 8;9(9):120. doi: 10.3390/cancers9090120.
8
The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.质子治疗的循证探索:基于模型的方法与精准医学。
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):30-36. doi: 10.1016/j.ijrobp.2015.10.004. Epub 2015 Oct 9.
9
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.基于支持向量机的早期非小细胞肺癌立体定向体部放疗后局部肿瘤控制的预测。
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8. doi: 10.1016/j.ijrobp.2013.11.216. Epub 2014 Jan 7.
10
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.质子放射治疗中基于模型的方法以减少副作用为目标的患者选择。
Radiother Oncol. 2013 Jun;107(3):267-73. doi: 10.1016/j.radonc.2013.05.007. Epub 2013 Jun 5.